Free Trial

Intra-Cellular Therapies (ITCI) Stock Trends and Sentiment

$65.62
+0.08 (+0.12%)
(As of 05/28/2024 ET)

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Follows Over Time

MarketBeat Searches Over Time

Recieve Intra-Cellular Therapies News and Ratings via Email

Sign-up to receive the latest news and ratings for ITCI and its competitors with MarketBeat's FREE daily newsletter.

Related Companies and Tools

This page (NASDAQ:ITCI) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners